Approved

Palmitoyl Tripeptide-1: Uses, Mechanism, and Evidence

Molecular formulaC30H54N6O5
Molecular weight578.8 g/mol
Registered trials0
PubChem CID10231864
Brand namesBUDDATE REGES INTENSIVE TREATMENT

Anyone reading a skin cream label may wonder what an ingredient like palmitoyl tripeptide-1 actually does and how it is meant to be used. This overview draws only on the labeling and identifiers on file for this compound.

Key takeaways

  • Palmitoyl tripeptide-1 is formulated into a topical cosmetic cream product.
  • It appears under the brand name Buddate Reges Intensive Treatment.
  • The labeled directions describe applying the cream to the body and massaging it in.
  • No boxed warning is present on the label.
  • The compound has the molecular formula C30H54N6O5 and a molecular weight of 578.8.

What palmitoyl tripeptide-1 is

Palmitoyl tripeptide-1 is a peptide compound identified by PubChem CID 10231864. It is marketed as an ingredient in a topical cosmetic treatment cream rather than as a prescription drug with a defined pharmacologic class on file.

What palmitoyl tripeptide-1 is approved for

The available labeling describes cosmetic use: applying a generous amount of the cream to the body three times a day and massaging it into the skin. This product is sold under the brand name Buddate Reges Intensive Treatment. No boxed warning appears on the label.

What the evidence shows

No registered clinical trials are on file for palmitoyl tripeptide-1 in the data reviewed.

Reported side effects

No adverse event reports are on file for this compound in the data reviewed.

FAQ

What is palmitoyl tripeptide-1 used for?
Based on the available labeling, palmitoyl tripeptide-1 is formulated into a topical cosmetic cream intended to be applied to the body and massaged into the skin. It is marketed under the brand name Buddate Reges Intensive Treatment. It is not labeled as a prescription medication with a defined drug class.
Does palmitoyl tripeptide-1 have a boxed warning?
No, the label on file for palmitoyl tripeptide-1 does not carry a boxed warning.
Is there clinical trial data for palmitoyl tripeptide-1?
The data reviewed shows no registered clinical trials for palmitoyl tripeptide-1. This means there is no trial-based evidence on file to summarize for this compound.
What is the chemical identity of palmitoyl tripeptide-1?
Palmitoyl tripeptide-1 has the molecular formula C30H54N6O5 and a molecular weight of 578.8. It is catalogued under PubChem CID 10231864.
Are there known side effects of palmitoyl tripeptide-1?
No adverse event reports are on file for palmitoyl tripeptide-1 in the data reviewed. This means no reported side-effect pattern is currently available to summarize.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: DailyMed label PubChem (CID 10231864) ClinicalTrials.gov

Updated 2026-09-19